SCPH (scpharmaceuticals.com) Future Price to Earnings

Official company branding of scPharmaceuticals (SCPH)

scPharmaceuticals Inc. (SCPH) business is fully focused on the US market, which eliminates cross-border risks and external political influence. The price trajectory shown below for securities with the 0.00 indicator links fundamental factors with market dynamics. The company's financial success is based on the commercialization of patented wearable gadgets and medications for treating edema associated with cardiac pathologies.

scPharmaceuticals Inc. - SCPH Market Cap to Future Earnings Ratio (period 07/04/2022 - 10/18/2025)

Summary analytical data breakdowns for scPharma (SCPH)

- current price and projected stock value:
Fundamental valuation:SCPH scPharmaceuticals
Brand item of scPharmaceuticals Inc.

Investors utilize asset filtering via forward multiples to identify undervalued companies. This metric correlates current market capitalization with expected net income, determining the cost of one dollar of future earnings. For scPharmaceuticals Inc. (SCPH), this calculation reflects the efficiency of heart pump commercialization against personnel costs. An analysis of the company's forward P/E multiple allows for an assessment of business scaling rates. The indicator's dynamics help identify either a fundamental bottom or a value trap in a timely manner.

Main competitors

Projected Price to Earnings HLN (Haleon)|KVUE (Kenvue Inc) - Future Price to Earnings Multiple|Future Price to Earnings Verona Pharma Corp VRNA|Jyong Bio (MENS) - Projected Price to Earnings Ratio|LGND: Projected Price to Earnings|amneal.com - Market Cap to Future Earnings Ratio|PRGO: Forward P/E Multiple|Alvotech S.A. - Future Price to Earnings Multiple|LQDA (Liquidia Technologies) - Forward P/E Multiple|Projected Price to Earnings Ratio Galapagos Corp GLPG|Future Price to Earnings ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Future Price to Earnings Multiple|Future Price to Earnings Amphastar Pharmaceuticals, Inc. AMPH|Market Cap to Projected Earnings Pacira Pharmaceuticals (PCRX)|ARS Pharma - Forward P/E Multiple|Theravance Corp (TBPH) - Projected Price to Earnings|Aquestive Therapeutics (AQST) - Future Price to Earnings|Price to Expected Earnings Ratio TECX (Tectonic Therapeutic)|TNXP (Tonix Pharmaceuticals Holding Corp.) - Forward P/E Multiple|SXTC: Future Price to Earnings Multiple|Forward P/E Multiple EPRX|Forward P/E Multiple BioHarvest Sciences Inc (BHST)|Future Price to Earnings eXoZymes Inc EXOZ|Future Price to Earnings Multiple ORMP|ENTX - Future Price to Earnings|MindWalk Holdings, Inc. (HYFT) - Projected Price to Earnings|ABVC: Forward P/E Multiple|Cumberland Corp (CPIX) - Forward P/E Multiple|QNTM (Quantum BioPharma Ltd) - Forward P/E Multiple|Projected Price to Earnings fibrogen.com (FGEN)|Forward P/E Multiple TELO|RANI - Projected Price to Earnings Ratio|Synergy CHC - Projected Price to Earnings|Forward P/E Multiple Rallybio Corp RLYB|LEXX: Projected Price to Earnings|pulmatrix.com - Market Cap to Future Earnings Ratio|PTHL: Forward P/E Multiple|APM - Market Cap to Projected Earnings|LYRA (Lyra Therapeutics, Inc) - Forward P/E Multiple|Projected Price to Earnings Impact BioMedical, Inc. (IBO)|Forward P/E Multiple TNFA|Forward P/E Multiple cbdmd.com (YCBD)|Future Price to Earnings PainReform PRFX|Altamira Therapeutics Ltd - Future Price to Earnings|LIPO - Future Price to Earnings|Market Cap to Projected Earnings OptiNose Corp OPTN|PIRS (Pieris Pharmaceuticals) - Projected Price to Earnings|procapsgroup.com - Future Price to Earnings Multiple|PTPI (Petros Pharmaceuticals, Inc.) - Forward P/E Multiple|Qilian International Holding Group (QLI) - Market Cap to Projected Earnings|Future Price to Earnings ACELYRIN, Inc. (SLRN)|TFF Pharmaceuticals, Inc - Price to Future Earnings Ratio